DNA
$8.14
Revenue | $89.05Mn |
Net Profits | $-56.4Mn |
Net Profit Margins | -63.34% |
Ginkgo Bioworks Holdings Inc’s revenue jumped 60.65% since last year same period to $89.05Mn in the Q3 2024. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 58.43% jump in its revenue since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit jumped 81.38% since last year same period to $-56.4Mn in the Q3 2024. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 74.03% jump in its net profits since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit margin jumped 88.41% since last year same period to -63.34% in the Q3 2024. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 83.61% jump in its net profit margins since last 3-months.
EPS Estimate Current Year | -0.08 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.08.
Earning Per Share (EPS) | -1.08 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) fell -575% since last year same period to -1.08 in the Q3 2024. This indicates that the Ginkgo Bioworks Holdings Inc has generated -575% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-08 | -3.12 | -4.4 | -41.03% |
2024-05-09 | -0.08 | -0.08 | 0% |
2024-11-12 | -3.32 | -1.08 | 67.49% |